杭州派特赛思生物医学技术有限公司成立，注册资本300万人民币

Company Overview - Hangzhou Paitesis Biomedical Technology Co., Ltd. was recently established with a registered capital of 3 million RMB [1][2] - The legal representative of the company is Jin Bolan [2] Shareholding Structure - The shareholding structure is as follows: - Shanghai Feichangmei Cosmetics Co., Ltd. holds 63% - Weidao (Hangzhou) Network Technology Co., Ltd. holds 27% - Huangshan Chuyuan Biotechnology Co., Ltd. holds 10% [1] Business Scope - The company's business scope includes: - Medical research and experimental development - Research and experimental development (excluding human stem cells, gene diagnosis, and treatment technology development and application) - Cell technology research and application - Natural science research and experimental development - Human stem cell technology development and application - Wholesale of pet food and supplies - Research and development of biological feed - Sales of livestock and fishery feed - Sales of feed raw materials - Retail of pet food and supplies - Technical services, development, consulting, exchange, transfer, and promotion - Wholesale of arts and crafts and collectibles (excluding ivory and its products) - Sales of arts and crafts and ceremonial supplies (excluding ivory and its products) - Sales of electronic products - Import and export of goods and technology (excluding projects that require approval) [1] Licensing Projects - The company is authorized to engage in: - Retail of pharmaceuticals - Clinical trial services for drugs - Animal diagnosis and treatment (subject to approval by relevant authorities) [1]